Literature DB >> 24296891

Maternal hormonal interventions as a risk factor for Autism Spectrum Disorder: an epidemiological assessment from India.

Madhu Poornima Mamidala1, Anupama Polinedi, P T V Praveen Kumar, N Rajesh, Omsai Ramesh Vallamkonda, Vrajesh Udani, Nidhi Singhal, Vidya Rajesh.   

Abstract

Globalization and women empowerment have led to stressful life among Indian women. This stress impairs women's hormonal makeup and menstrual cycle, leading to infertility. National Family Health Survey-3 (NFHS-3) reports a decline in fertility status in India, indicating a rise in various infertility treatments involving hormonal interventions. No studies are available from India on the risk association link between maternal hormonal treatments and ASD. Hence, this study explores the association of maternal hormonal interventions with risk for ASD. Parents of 942 children (471 ASD and 471 controls) across 9 cities in India participated in the questionnaire-based study. The questionnaire was pilot tested and validated for its content and reliability as a psychometric instrument. Data collection was done at 70 centres through direct interaction with parents and with the help of trained staff. Statistical analysis of data was carried out using SAS 9.1.3. Out of the 471 ASD cases analysed, 58 mothers had undergone hormonal interventions (12.3 percent) while there were only 22 mothers among controls who underwent hormonal interventions (4.6 percent). According to logistic regression analysis maternal hormonal intervention (OR=2.24) was a significant risk factor for ASD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24296891     DOI: 10.1007/s12038-013-9376-x

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  21 in total

1.  From 'obstetric complications' to a maternal-foetal origin hypothesis of mood disorder.

Authors:  Veronica O'Keane; Jan Scott
Journal:  Br J Psychiatry       Date:  2005-05       Impact factor: 9.319

Review 2.  Fertility drugs and ovarian cancer.

Authors:  E Glud; S K Kjaer; R Troisi; L A Brinton
Journal:  Epidemiol Rev       Date:  1998       Impact factor: 6.222

Review 3.  Early life programming and neurodevelopmental disorders.

Authors:  Tracy L Bale; Tallie Z Baram; Alan S Brown; Jill M Goldstein; Thomas R Insel; Margaret M McCarthy; Charles B Nemeroff; Teresa M Reyes; Richard B Simerly; Ezra S Susser; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2010-08-15       Impact factor: 13.382

4.  Prenatal and birth complications in autism.

Authors:  M Brimacombe; X Ming; M Lamendola
Journal:  Matern Child Health J       Date:  2006-10-12

5.  Assisted reproductive technology and risk for autism spectrum disorder.

Authors:  Ditza A Zachor; E Ben Itzchak
Journal:  Res Dev Disabil       Date:  2011-06-11

6.  Correlation of serum hormone concentrations in maternal and umbilical cord samples.

Authors:  Rebecca Troisi; Nancy Potischman; James M Roberts; Gail Harger; Nina Markovic; Bernard Cole; David Lykins; Pentti Siiteri; Robert N Hoover
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

7.  Fetal testosterone and autistic traits.

Authors:  Bonnie Auyeung; Simon Baron-Cohen; Emma Ashwin; Rebecca Knickmeyer; Kevin Taylor; Gerald Hackett
Journal:  Br J Psychol       Date:  2008-06-10

Review 8.  Autism: A review for family physicians.

Authors:  Sunil Karande
Journal:  Indian J Med Sci       Date:  2006-05

9.  Foetal testosterone and autistic traits in 18 to 24-month-old children.

Authors:  Bonnie Auyeung; Kevin Taylor; Gerald Hackett; Simon Baron-Cohen
Journal:  Mol Autism       Date:  2010-07-12       Impact factor: 7.509

Review 10.  Association of increased prenatal estrogen with risk factors for schizophrenia.

Authors:  James S Brown
Journal:  Schizophr Bull       Date:  2010-01-06       Impact factor: 9.306

View more
  8 in total

1.  Maternal polycystic ovarian syndrome in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  Maria Katsigianni; Vasilios Karageorgiou; Irene Lambrinoudaki; Charalampos Siristatidis
Journal:  Mol Psychiatry       Date:  2019-03-13       Impact factor: 15.992

2.  Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder.

Authors:  Brittany D Needham; Mark D Adame; Gloria Serena; Destanie R Rose; Gregory M Preston; Mary C Conrad; A Stewart Campbell; David H Donabedian; Alessio Fasano; Paul Ashwood; Sarkis K Mazmanian
Journal:  Biol Psychiatry       Date:  2020-10-10       Impact factor: 13.382

Review 3.  Are Attributes of Pregnancy and the Delivery Room Experience Related to Development of Autism? A Review of the Perinatal and Labor Risk Factors and Autism.

Authors:  Naveen Dhawan; Blaze Emerson; Romana Popara; Catherine Lin; Adam Rawji; Rita Zeiden; Leeda Rashid; Pwint Phyu; Jaya Bahl; Vineet Gupta
Journal:  Int Sch Res Notices       Date:  2014-10-01

4.  Resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ERβ activation.

Authors:  Weiguo Xie; Xiaohu Ge; Ling Li; Athena Yao; Xiaoyan Wang; Min Li; Xiang Gong; Zhigang Chu; Zhe Lu; Xiaodong Huang; Yun Jiao; Yifei Wang; Meifang Xiao; Haijia Chen; Wei Xiang; Paul Yao
Journal:  Mol Autism       Date:  2018-08-02       Impact factor: 7.509

5.  Prenatal Progestin Exposure Is Associated With Autism Spectrum Disorders.

Authors:  Ling Li; Min Li; Jianping Lu; Xiaohu Ge; Weiguo Xie; Zichen Wang; Xiaoling Li; Chao Li; Xiaoyan Wang; Yan Han; Yifei Wang; Liyan Zhong; Wei Xiang; Xiaodong Huang; Haijia Chen; Paul Yao
Journal:  Front Psychiatry       Date:  2018-11-19       Impact factor: 4.157

6.  A systematic review and meta-analysis of the association between maternal polycystic ovary syndrome and neuropsychiatric disorders in children.

Authors:  Pallavi Dubey; Bhaskar Thakur; Sheryl Rodriguez; Jessika Cox; Sheralyn Sanchez; Anacani Fonseca; Sireesha Reddy; Deborah Clegg; Alok Kumar Dwivedi
Journal:  Transl Psychiatry       Date:  2021-11-08       Impact factor: 6.222

7.  Prenatal Progestin Exposure-Mediated Oxytocin Suppression Contributes to Social Deficits in Mouse Offspring.

Authors:  Saijun Huang; Jiaying Zeng; Ruoyu Sun; Hong Yu; Haimou Zhang; Xi Su; Paul Yao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-15       Impact factor: 5.555

8.  Androgens Tend to Be Higher, but What about Altered Progesterone Metabolites in Boys and Girls with Autism?

Authors:  Benedikt Gasser; Johann Kurz; Genevieve Escher; Hiten D Mistry; Markus G Mohaupt
Journal:  Life (Basel)       Date:  2022-07-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.